Skip to main content
Erschienen in: Supportive Care in Cancer 2/2017

22.10.2016 | Original Article

Psychometric properties and measurement equivalence of the English and Chinese versions of the Beck Anxiety Inventory in patients with breast cancer

verfasst von: Yu Ke, Terence Ng, Hui Ling Yeo, Maung Shwe, Yan Xiang Gan, Alexandre Chan

Erschienen in: Supportive Care in Cancer | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

There is a lack of psychometric data for both the English and Chinese versions of Beck Anxiety Inventory (BAI) to support its usage among breast cancer patients. This study examined the psychometric properties and measurement equivalence of the English and Chinese versions of BAI among breast cancer patients in Singapore.

Methods

Patients were recruited from two major cancer centers in Singapore. The criterion and construct validity of BAI was assessed by its correlation strength with (1) the emotional functioning subdomain of EORTC QLQ-C30 and (2) constructs related to anxiety, namely fatigue, dyspnea, and quality of life. The known-group validity was assessed according to the patients’ breast cancer stage, religious beliefs, and emotional functioning levels. The internal consistency of the BAI domains was evaluated using Cronbach’s alpha coefficient. Regression analysis was performed to compare the BAI total and domain scores between the two language versions.

Results

Data from 244 patients (144 English-speaking and 100 Chinese-speaking) were analyzed. For both language versions, the BAI total scores correlated moderately with the EORTC QLQ-C30 emotional functioning subdomain (r = −0.655 and −0.601). Correlations with fatigue, quality of life, and dyspnea were moderate (|r| = 0.456–0.606). Patients with poorer emotional functioning reported higher anxiety levels, establishing known-group validity. All BAI domains demonstrated satisfactory internal consistencies (α = 0.74–0.87), except for the panic domain (α = 0.57–0.61). Possible measurement equivalence between the language versions was established.

Conclusion

Both English and Chinese versions of BAI are valid, reliable, and possibly equivalent for future use.
Literatur
2.
Zurück zum Zitat Pedersen AE, Sawatzky J-A, Hack TF (2010) The sequelae of anxiety in breast cancer: a human response to illness model. Oncol Nurs Forum 37(4):469–475CrossRefPubMed Pedersen AE, Sawatzky J-A, Hack TF (2010) The sequelae of anxiety in breast cancer: a human response to illness model. Oncol Nurs Forum 37(4):469–475CrossRefPubMed
3.
Zurück zum Zitat Burgess C, Cornelius V, Love S et al (2005) Depression and anxiety in women with early breast cancer: five year observational cohort study. BMJ: British Medical Journal 330(7493):702–705CrossRefPubMedPubMedCentral Burgess C, Cornelius V, Love S et al (2005) Depression and anxiety in women with early breast cancer: five year observational cohort study. BMJ: British Medical Journal 330(7493):702–705CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat So WKW, Marsh G, Ling WM et al (2010) Anxiety, depression and quality of life among Chinese breast cancer patients during adjuvant therapy. Eur J Oncol Nurs 14(1):17–22CrossRefPubMed So WKW, Marsh G, Ling WM et al (2010) Anxiety, depression and quality of life among Chinese breast cancer patients during adjuvant therapy. Eur J Oncol Nurs 14(1):17–22CrossRefPubMed
5.
Zurück zum Zitat Schreier AM, Williams SA (2004) Anxiety and quality of life of women who receive radiation or chemotherapy for breast cancer. Oncol Nurs Forum 31(1):127–130CrossRefPubMed Schreier AM, Williams SA (2004) Anxiety and quality of life of women who receive radiation or chemotherapy for breast cancer. Oncol Nurs Forum 31(1):127–130CrossRefPubMed
6.
Zurück zum Zitat Spiegel D, Riba MB (2015) Managing anxiety and depression during treatment. Breast J 21(1):97–103CrossRefPubMed Spiegel D, Riba MB (2015) Managing anxiety and depression during treatment. Breast J 21(1):97–103CrossRefPubMed
7.
8.
Zurück zum Zitat Jones SL, Hadjistavropoulos HD, Gullickson K (2014) Understanding health anxiety following breast cancer diagnosis. Psychology, health & medicine 19(5):525–535CrossRef Jones SL, Hadjistavropoulos HD, Gullickson K (2014) Understanding health anxiety following breast cancer diagnosis. Psychology, health & medicine 19(5):525–535CrossRef
9.
Zurück zum Zitat Cheung YT, Lee HH-L, Chan A (2013) Exploring clinical determinants and anxiety symptom domains among Asian breast cancer patients. Support Care Cancer 21(8):2185–2194CrossRefPubMed Cheung YT, Lee HH-L, Chan A (2013) Exploring clinical determinants and anxiety symptom domains among Asian breast cancer patients. Support Care Cancer 21(8):2185–2194CrossRefPubMed
10.
Zurück zum Zitat Julian LJ (2011) Measures of anxiety: state-trait anxiety inventory (STAI), Beck Anxiety Inventory (BAI), and hospital anxiety and depression scale-anxiety (HADS-A). Arthritis Care Res (Hoboken) 63(Suppl 11):S467–S472CrossRef Julian LJ (2011) Measures of anxiety: state-trait anxiety inventory (STAI), Beck Anxiety Inventory (BAI), and hospital anxiety and depression scale-anxiety (HADS-A). Arthritis Care Res (Hoboken) 63(Suppl 11):S467–S472CrossRef
11.
Zurück zum Zitat Beck AT, Epstein N, Brown G, Steer RA (1988) An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 56(6):893–897CrossRefPubMed Beck AT, Epstein N, Brown G, Steer RA (1988) An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 56(6):893–897CrossRefPubMed
12.
Zurück zum Zitat Fydrich T, Dowdall D, Chambless DL (1992) Reliability and validity of the Beck anxiety inventory. Journal of Anxiety Disorders 6(1):55–61CrossRef Fydrich T, Dowdall D, Chambless DL (1992) Reliability and validity of the Beck anxiety inventory. Journal of Anxiety Disorders 6(1):55–61CrossRef
13.
Zurück zum Zitat de Beurs E, Wilson KA, Chambless DL et al (1997) Convergent and divergent validity of the Beck Anxiety Inventory for patients with panic disorder and agoraphobia. Depression and anxiety 6(4):140–146CrossRefPubMed de Beurs E, Wilson KA, Chambless DL et al (1997) Convergent and divergent validity of the Beck Anxiety Inventory for patients with panic disorder and agoraphobia. Depression and anxiety 6(4):140–146CrossRefPubMed
14.
Zurück zum Zitat Wetherell JL, Areán PA (1997) Psychometric evaluation of the Beck Anxiety Inventory with older medical patients. Psychol Assess 9(2):136–144CrossRef Wetherell JL, Areán PA (1997) Psychometric evaluation of the Beck Anxiety Inventory with older medical patients. Psychol Assess 9(2):136–144CrossRef
15.
Zurück zum Zitat Osman A, Barrios FX, Aukes D et al (1993) The Beck anxiety inventory: psychometric properties in a community population. J Psychopathol Behav Assess 15(4):287–297CrossRef Osman A, Barrios FX, Aukes D et al (1993) The Beck anxiety inventory: psychometric properties in a community population. J Psychopathol Behav Assess 15(4):287–297CrossRef
16.
Zurück zum Zitat Osman A, Kopper BA, Barrios FX et al (1997) The Beck anxiety inventory: reexamination of factor structure and psychometric properties. J Clin Psychol 53(1):7–14CrossRefPubMed Osman A, Kopper BA, Barrios FX et al (1997) The Beck anxiety inventory: reexamination of factor structure and psychometric properties. J Clin Psychol 53(1):7–14CrossRefPubMed
17.
Zurück zum Zitat Creamer M, Foran J, Bell R (1995) The Beck Anxiety Inventory in a non-clinical sample. Behav Res Ther 33(4):477–485CrossRefPubMed Creamer M, Foran J, Bell R (1995) The Beck Anxiety Inventory in a non-clinical sample. Behav Res Ther 33(4):477–485CrossRefPubMed
18.
Zurück zum Zitat Magán I, Sanz J, García-Vera MP (2008) Psychometric properties of a Spanish version of the Beck Anxiety Inventory (BAI) in general population. The Spanish journal of psychology 11(2):626PubMed Magán I, Sanz J, García-Vera MP (2008) Psychometric properties of a Spanish version of the Beck Anxiety Inventory (BAI) in general population. The Spanish journal of psychology 11(2):626PubMed
19.
Zurück zum Zitat Yap KY-L, Low XH, Chui WK et al (2012) Computational prediction of state anxiety in Asian patients with cancer susceptible to chemotherapy-induced nausea and vomiting. J Clin Psychopharmacol 32(2):207–217CrossRefPubMed Yap KY-L, Low XH, Chui WK et al (2012) Computational prediction of state anxiety in Asian patients with cancer susceptible to chemotherapy-induced nausea and vomiting. J Clin Psychopharmacol 32(2):207–217CrossRefPubMed
20.
Zurück zum Zitat Luo N, Thumboo J (2004) Factors influencing health-related quality of life of Asians with anxiety disorders in Singapore. Qual Life Res 13(2):557–565CrossRefPubMed Luo N, Thumboo J (2004) Factors influencing health-related quality of life of Asians with anxiety disorders in Singapore. Qual Life Res 13(2):557–565CrossRefPubMed
21.
Zurück zum Zitat Fayers PM, Machin D (2000) Quality of life: assessment, analysis and interpretation. John Wiley & Sons, Chichester; SingaporeCrossRef Fayers PM, Machin D (2000) Quality of life: assessment, analysis and interpretation. John Wiley & Sons, Chichester; SingaporeCrossRef
22.
Zurück zum Zitat Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365–376CrossRefPubMed Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365–376CrossRefPubMed
23.
Zurück zum Zitat Luo N (2005) The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30): validation of English version in Singapore. Qual Life Res 14(4):1181–1186CrossRefPubMed Luo N (2005) The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30): validation of English version in Singapore. Qual Life Res 14(4):1181–1186CrossRefPubMed
24.
Zurück zum Zitat Zhao H (2000) Translation and validation of the standard Chinese version of the EORTC QLQ-C30. Qual Life Res 9(2):129–137CrossRefPubMed Zhao H (2000) Translation and validation of the standard Chinese version of the EORTC QLQ-C30. Qual Life Res 9(2):129–137CrossRefPubMed
25.
Zurück zum Zitat Shih C-L, Chen C-H, Sheu C-F et al (2013) Validating and improving the reliability of the EORTC qlq-c30 using a multidimensional Rasch model. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 16(5):848–854CrossRef Shih C-L, Chen C-H, Sheu C-F et al (2013) Validating and improving the reliability of the EORTC qlq-c30 using a multidimensional Rasch model. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 16(5):848–854CrossRef
26.
Zurück zum Zitat Kontodimopoulos N, Ntinoulis K, Niakas D (2011) Validity of the Greek EORTC QLQ-C30 and QLQ-BR23 for measuring health-related quality of life in breast cancer patients. European Journal of Cancer Care 20(3):354–361CrossRefPubMed Kontodimopoulos N, Ntinoulis K, Niakas D (2011) Validity of the Greek EORTC QLQ-C30 and QLQ-BR23 for measuring health-related quality of life in breast cancer patients. European Journal of Cancer Care 20(3):354–361CrossRefPubMed
27.
Zurück zum Zitat Taylor R (1990) Interpretation of the correlation coefficient: a basic review. Journal of Diagnostic Medical Sonography 6(1):35–39CrossRef Taylor R (1990) Interpretation of the correlation coefficient: a basic review. Journal of Diagnostic Medical Sonography 6(1):35–39CrossRef
28.
Zurück zum Zitat So WKW, Marsh G, Ling WM et al (2009) The symptom cluster of fatigue, pain, anxiety, and depression and the effect on the quality of life of women receiving treatment for breast cancer: a multicenter study. Oncol Nurs Forum 36(4):E205CrossRefPubMed So WKW, Marsh G, Ling WM et al (2009) The symptom cluster of fatigue, pain, anxiety, and depression and the effect on the quality of life of women receiving treatment for breast cancer: a multicenter study. Oncol Nurs Forum 36(4):E205CrossRefPubMed
29.
Zurück zum Zitat Bodtcher H, Bidstrup PE, Andersen I et al (2015) Fatigue trajectories during the first 8 months after breast cancer diagnosis. Qual Life Res 24(11):2671–2679CrossRefPubMed Bodtcher H, Bidstrup PE, Andersen I et al (2015) Fatigue trajectories during the first 8 months after breast cancer diagnosis. Qual Life Res 24(11):2671–2679CrossRefPubMed
30.
Zurück zum Zitat De Vries J, Vd S, der Ent FWC V, JA R (2006) Trait anxiety predicts fatigue in women with early stage breast cancer. EJC Suppl 4(2):91–92CrossRef De Vries J, Vd S, der Ent FWC V, JA R (2006) Trait anxiety predicts fatigue in women with early stage breast cancer. EJC Suppl 4(2):91–92CrossRef
31.
Zurück zum Zitat Vahdaninia M, Omidvari S, Montazeri A (2010) What do predict anxiety and depression in breast cancer patients? A follow-up study. Soc Psychiatry Psychiatr Epidemiol 45(3):355–361CrossRefPubMed Vahdaninia M, Omidvari S, Montazeri A (2010) What do predict anxiety and depression in breast cancer patients? A follow-up study. Soc Psychiatry Psychiatr Epidemiol 45(3):355–361CrossRefPubMed
32.
Zurück zum Zitat Jd V, Roukema JA, Mertens MC et al (2013) Cancer or no cancer: the influence of trait anxiety and diagnosis on quality of life with breast cancer and benign disease: a prospective, longitudinal study. World J Surg 37(9):2140–2147CrossRef Jd V, Roukema JA, Mertens MC et al (2013) Cancer or no cancer: the influence of trait anxiety and diagnosis on quality of life with breast cancer and benign disease: a prospective, longitudinal study. World J Surg 37(9):2140–2147CrossRef
33.
Zurück zum Zitat Leivseth L, Nilsen TIL, Mai X-M et al.. Lung function and anxiety in association with dyspnoea: the HUNT study. Respir Med 106(8):1148–1157 Leivseth L, Nilsen TIL, Mai X-M et al.. Lung function and anxiety in association with dyspnoea: the HUNT study. Respir Med 106(8):1148–1157
34.
Zurück zum Zitat Cheung YT, Lim SR, Shwe M et al (2013) Psychometric properties and measurement equivalence of the English and Chinese versions of the functional assessment of cancer therapy-cognitive in Asian patients with breast cancer. Value Health 16(6):1001–1013CrossRefPubMed Cheung YT, Lim SR, Shwe M et al (2013) Psychometric properties and measurement equivalence of the English and Chinese versions of the functional assessment of cancer therapy-cognitive in Asian patients with breast cancer. Value Health 16(6):1001–1013CrossRefPubMed
35.
Zurück zum Zitat Mutchnick MG, Williams JM (2012) Anxiety and memory test performance. Applied neuropsychology Adult 19(4):241CrossRefPubMed Mutchnick MG, Williams JM (2012) Anxiety and memory test performance. Applied neuropsychology Adult 19(4):241CrossRefPubMed
36.
Zurück zum Zitat Cronbach LJ (1951) Coefficient alpha and the internal structure of tests. Psychometrika 16(3):297–334CrossRef Cronbach LJ (1951) Coefficient alpha and the internal structure of tests. Psychometrika 16(3):297–334CrossRef
37.
Zurück zum Zitat Chadwick D (2001) Monotherapy comparative trials: equivalence and differences in clinical trials. Epilepsy Res 45(1):101–103CrossRefPubMed Chadwick D (2001) Monotherapy comparative trials: equivalence and differences in clinical trials. Epilepsy Res 45(1):101–103CrossRefPubMed
38.
Zurück zum Zitat Jones B, Jarvis P, Lewis JA, Ebbutt AF (1996) Trials to assess equivalence: the importance of rigorous methods. BMJ: British Medical Journal 313(7048):36–39CrossRefPubMedPubMedCentral Jones B, Jarvis P, Lewis JA, Ebbutt AF (1996) Trials to assess equivalence: the importance of rigorous methods. BMJ: British Medical Journal 313(7048):36–39CrossRefPubMedPubMedCentral
39.
Zurück zum Zitat Herdman M, Fox-Rushby J, Badia X (1998) A model of equivalence in the cultural adaptation of HRQoL instruments: the universalist approach. Qual Life Res 7(4):323–335CrossRefPubMed Herdman M, Fox-Rushby J, Badia X (1998) A model of equivalence in the cultural adaptation of HRQoL instruments: the universalist approach. Qual Life Res 7(4):323–335CrossRefPubMed
40.
Zurück zum Zitat Cheung YB, Thumboo J, Goh C et al (2004) The equivalence and difference between the English and Chinese versions of two major, cancer-specific, health-related quality-of-life questionnaires. Cancer 101(12):2874–2880CrossRefPubMed Cheung YB, Thumboo J, Goh C et al (2004) The equivalence and difference between the English and Chinese versions of two major, cancer-specific, health-related quality-of-life questionnaires. Cancer 101(12):2874–2880CrossRefPubMed
41.
Zurück zum Zitat Cohen J (1988) Statistical power analysis for the behavioral sciences. L. Erlbaum Associates, Hillsdale, N.J Cohen J (1988) Statistical power analysis for the behavioral sciences. L. Erlbaum Associates, Hillsdale, N.J
42.
Zurück zum Zitat Zwingmann C, MüLler C, Körber J, Murken S (2008) Religious commitment, religious coping and anxiety: a study in German patients with breast cancer. European Journal of Cancer Care 17(4):361–370CrossRefPubMed Zwingmann C, MüLler C, Körber J, Murken S (2008) Religious commitment, religious coping and anxiety: a study in German patients with breast cancer. European Journal of Cancer Care 17(4):361–370CrossRefPubMed
43.
Zurück zum Zitat Shiah Y-J, Chang F, Chiang S-K et al (2015) Religion and health: anxiety, religiosity, meaning of life and mental health. J Relig Health 54(1):35–45CrossRefPubMed Shiah Y-J, Chang F, Chiang S-K et al (2015) Religion and health: anxiety, religiosity, meaning of life and mental health. J Relig Health 54(1):35–45CrossRefPubMed
44.
Zurück zum Zitat McCoubrie RC, Davies AN (2006) Is there a correlation between spirituality and anxiety and depression in patients with advanced cancer? Support Care Cancer 14(4):379–385CrossRefPubMed McCoubrie RC, Davies AN (2006) Is there a correlation between spirituality and anxiety and depression in patients with advanced cancer? Support Care Cancer 14(4):379–385CrossRefPubMed
45.
Zurück zum Zitat Gioiella ME, Berkman B, Robinson M (1998) Spirituality and quality of life in gynecologic oncology patients. Cancer Pract 6(6):333–338CrossRefPubMed Gioiella ME, Berkman B, Robinson M (1998) Spirituality and quality of life in gynecologic oncology patients. Cancer Pract 6(6):333–338CrossRefPubMed
46.
Zurück zum Zitat Verburg K, Griez E, Meijer J, Pols H (1995) Respiratory disorders as a possible predisposing factor for panic disorder. J Affect Disord 33(2):129–134CrossRefPubMed Verburg K, Griez E, Meijer J, Pols H (1995) Respiratory disorders as a possible predisposing factor for panic disorder. J Affect Disord 33(2):129–134CrossRefPubMed
47.
Zurück zum Zitat Higginson IJ, Costantini M (2008) Dying with cancer, living well with advanced cancer. Eur J Cancer 44(10):1414–1424CrossRefPubMed Higginson IJ, Costantini M (2008) Dying with cancer, living well with advanced cancer. Eur J Cancer 44(10):1414–1424CrossRefPubMed
48.
Zurück zum Zitat Paiva CE, Carneseca EC, Barroso EM et al (2014) Further evaluation of the EORTC QLQ-C30 psychometric properties in a large Brazilian cancer patient cohort as a function of their educational status. Support Care Cancer 22(8):2151–2160PubMed Paiva CE, Carneseca EC, Barroso EM et al (2014) Further evaluation of the EORTC QLQ-C30 psychometric properties in a large Brazilian cancer patient cohort as a function of their educational status. Support Care Cancer 22(8):2151–2160PubMed
49.
Zurück zum Zitat Pamuk GE, Harmandar F, Ermantaş N et al (2008) EORTC QLQ-C30 assessment in Turkish patients with hematological malignancies: association with anxiety and depression. Ann Hematol 87(4):305–310CrossRefPubMed Pamuk GE, Harmandar F, Ermantaş N et al (2008) EORTC QLQ-C30 assessment in Turkish patients with hematological malignancies: association with anxiety and depression. Ann Hematol 87(4):305–310CrossRefPubMed
Metadaten
Titel
Psychometric properties and measurement equivalence of the English and Chinese versions of the Beck Anxiety Inventory in patients with breast cancer
verfasst von
Yu Ke
Terence Ng
Hui Ling Yeo
Maung Shwe
Yan Xiang Gan
Alexandre Chan
Publikationsdatum
22.10.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 2/2017
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-016-3452-3

Weitere Artikel der Ausgabe 2/2017

Supportive Care in Cancer 2/2017 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.